These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17102897)

  • 1. Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis.
    Riaz Y; Mehta JS; Fernando A; Ferguson V
    Ann Acad Med Singap; 2006 Oct; 35(10):723-5. PubMed ID: 17102897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
    Dotan A; Kaiserman I; Kremer I; Ehrlich R; Bahar I
    Br J Ophthalmol; 2014 Feb; 98(2):252-5. PubMed ID: 24276695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.
    Heiligenhaus A; Steinmetz B; Lapuente R; Krallmann P; Althaus C; Steinkamp WK; Dick B
    Br J Ophthalmol; 1998 Jul; 82(7):810-5. PubMed ID: 9924378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.
    Siatiri H; Beheshtnezhad AH; Asghari H; Siatiri N; Moghimi S; Piri N
    Br J Ophthalmol; 2005 Nov; 89(11):1458-61. PubMed ID: 16234453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator for treatment of fibrin in endophthalmitis.
    Damji KF; O'Connor MD; Hill V
    Can J Ophthalmol; 2001 Aug; 36(5):269-71. PubMed ID: 11548143
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
    Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
    J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis of postcataract fibrin membranes in children.
    Leung AT; Lam DS; Rao SK
    J Cataract Refract Surg; 2000 Jan; 26(1):4; author reply 5. PubMed ID: 10646130
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.
    Osaadon P; Belfair N; Lavy I; Walter E; Levy J; Tuuminen R; Achiron A; Knyazer B
    Eur J Ophthalmol; 2022 Jan; 32(1):200-204. PubMed ID: 33719630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis of postcataract fibrin membranes in children.
    Mehta JS; Adams GG
    J Cataract Refract Surg; 2000 Jan; 26(1):4-5. PubMed ID: 10646131
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.
    Wu TT; Wang HH
    Eye (Lond); 2009 Jan; 23(1):101-7. PubMed ID: 17901882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid development of band keratopathy of corneal graft associated with treatment with intracameral recombinant tissue plasminogen activator for postoperative fibrin reaction.
    Spitzer MS; Szurman P; Aisenbrey S; Rohrbach JM
    Eur J Ophthalmol; 2007; 17(3):433-6. PubMed ID: 17534830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracameral tissue plasminogen activator: management of a fibrin clot occluding a Molteno tube.
    Pastor SA; Schumann SP; Starita RJ; Fellman RL
    Ophthalmic Surg; 1993 Dec; 24(12):853-4. PubMed ID: 8115104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
    Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
    Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
    Wedrich A; Menapace R; Mühlbauer-Ries E
    Int Ophthalmol; 1994-1995; 18(5):277-80. PubMed ID: 7607808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome.
    Cakmak H; Kocatürk T
    Br J Ophthalmol; 2014 Aug; 98(8):1132. PubMed ID: 24759878
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant tissue plasminogen activator following paediatric cataract surgery.
    Mehta JS; Adams GG
    Br J Ophthalmol; 2000 Sep; 84(9):983-6. PubMed ID: 10966949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin reaction after uveitic cataract surgery: treatment and prevention.
    da Rocha Lima B; Pichi F; Nucci P; Srivastava SK; Lowder CY
    Eur J Ophthalmol; 2014; 24(4):626-8. PubMed ID: 24519510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
    Burnstein Y; Higginbotham EJ
    J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.
    Schmitz K; Greite JH; Bartenschlager EM
    Ger J Ophthalmol; 1995 Mar; 4(2):75-9. PubMed ID: 7795512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.